Amneal launches $250 million add-on term loan at 99.509 OID

By Sara Rosenberg

New York, March 23 – Amneal Pharmaceuticals LLC held a lender call on Thursday to launch a $250 million add-on term loan that is talked at Libor plus 350 basis points with a 1% Libor floor and an original issue discount of 99.509, according to a market source.

J.P. Morgan Securities LLC is the lead bank on the deal.

Proceeds will be used to fund a dividend and for general corporate purposes.

Amneal Pharmaceuticals is a Bridgewater, N.J.-based manufacturer of generic pharmaceuticals.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.